시장보고서
상품코드
1267528

세계의 혈당 모니터링 기기 시장(2023-2027년)

Global Blood Glucose Monitoring Devices Market 2023-2027

발행일: | 리서치사: TechNavio | 페이지 정보: 영문 165 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈당 모니터링 기기 시장을 모니터링하고, 2022년부터 2027년까지 74억 8,881만 달러, 예측기간 중 CAGR은 8.88%로 성장할 것으로 예측했습니다.

혈당 모니터링 기기 시장에 대해 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인과 과제, 약 25개 벤더를 커버하는 벤더 분석 등을 제공합니다.

현재 시장 시나리오, 최신 동향과 촉진요인, 시장 전체의 환경에 관한 최신 분석을 제공합니다. 시장은 세계의 당뇨병 부담 증가, 혈당 모니터링 기기의 기술적 진보, 혈당 모니터링 기기에 대한 상환 유무에 의해 견인되고 있습니다.

이 조사에서는 스마트 워치 기반 앱이 향후 몇 년간 혈당 모니터링 기기 시장 성장을 촉진하는 주요 이유 중 하나로 파악하고 있습니다. 또한 홈헬스케어 기기 도입이 진행되고, 번들 제품 마케팅 전략 채용이 증가해 시장 수요가 크게 확대될 것으로 생각됩니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 상황

  • 시장 생태계

제3장 시장 규모

  • 시장 정의
  • 시장별 분석
  • 시장 규모 2022
  • 시장 전망 2022-2027

제4장 시장 규모 실적

  • 혈당 모니터링 기기 세계 시장 2017-2021
  • 최종사용자 부문 분석 2017-2021
  • 제품 부문 분석 2017-2021
  • 지역별 분석 2017-2021
  • 국가별 분석 2017-2021

제5장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁의 위협
  • 시장 상황

제6장 시장 세분화 : 최종사용자별

  • 시장 부문
  • 비교 : 최종사용자별
  • 병원 : 시장 규모와 예측 2022-2027
  • 재택간병 : 시장 규모와 예측 2022-2027
  • 진단 센터 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 최종사용자별

제7장 시장 세분화 : 제품별

  • 시장 부문
  • 비교 : 제품별
  • SMBG : 시장 규모와 예측 2022-2027
  • CGM : 시장 규모와 예측 2022-2027
  • 란셋 : 시장 규모와 예측 2022-2027
  • 시장 기회 : 제품별

제8장 고객 상황

  • 고객 상황 개요

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측 2022-2027
  • 유럽 : 시장 규모와 예측 2022-2027
  • 아시아 : 시장 규모와 예측 2022-2027
  • 세계의 기타 지역 : 시장 규모와 예측 2022-2027
  • 미국 : 시장 규모와 예측 2022-2027
  • 독일 : 시장 규모와 예측 2022-2027
  • 영국 : 시장 규모와 예측 2022-2027
  • 캐나다 : 시장 규모와 예측 2022-2027
  • 일본 : 시장 규모와 예측 2022-2027
  • 지역 상황별 시장 기회

제10장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제11장 벤더 상황

  • 개요
  • 벤더 상황
  • 혼란 상황
  • 업계 위험

제12장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Dexcom Inc.
  • DiaMonTech AG
  • F. Hoffmann La Roche Ltd.
  • GlySens Inc.
  • Health Arx Technologies Pvt. Ltd.
  • Insulet Corp.
  • Medtronic Plc
  • Medtrum Technologies Inc.
  • Novo Nordisk AS
  • Sanofi SA
  • Senseonics Holdings Inc.
  • SFC Fluidics Inc.
  • Ypsomed AG

제13장 부록

KSM 23.05.19

Technavio has been monitoring the blood glucose monitoring devices market and is forecast to grow by USD 7488.81 mn during 2022-2027, accelerating at a CAGR of 8.88% during the forecast period. Our report on the blood glucose monitoring devices market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, technological advances in blood glucose monitoring devices, and the availability of reimbursement for blood glucose monitoring devices.

Technavio's blood glucose monitoring devices market is segmented as below:

By End-user

  • Hospitals
  • Home care
  • Diagnostic centers

By Product

  • SMBG
  • CGM
  • Lancets

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies smart watch-based apps as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years. Also, increasing adoption of home healthcare devices and increased adoption of bundled product marketing strategy will lead to sizable demand in the market.

  • Blood glucose monitoring devices market sizing
  • Blood glucose monitoring devices market forecast
  • Blood glucose monitoring devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Bigfoot Biomedical Inc., Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., Health Arx Technologies Pvt. Ltd., Insulet Corp., Level2 Medical Services P.A., Levels Health Inc., Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, PKvitality S.A.S., Sanofi SA, Senseonics Holdings Inc., SFC Fluidics Inc., Teladoc Health Inc., and Ypsomed AG. Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global blood glucose monitoring devices market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global blood glucose monitoring devices market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Hospitals - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
  • 6.4 Home care - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Home care - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Home care - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Home care - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Home care - Year-over-year growth 2022-2027 (%)
  • 6.5 Diagnostic centers - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Diagnostic centers - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Diagnostic centers - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Diagnostic centers - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by End-user
  • Exhibit 46: Market opportunity by End-user ($ million)
  • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 48: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 49: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 50: Chart on Comparison by Product
  • Exhibit 51: Data Table on Comparison by Product
  • 7.3 SMBG - Market size and forecast 2022-2027
  • Exhibit 52: Chart on SMBG - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on SMBG - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on SMBG - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on SMBG - Year-over-year growth 2022-2027 (%)
  • 7.4 CGM - Market size and forecast 2022-2027
  • Exhibit 56: Chart on CGM - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on CGM - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on CGM - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on CGM - Year-over-year growth 2022-2027 (%)
  • 7.5 Lancets - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Lancets - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Lancets - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Lancets - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Lancets - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Product
  • Exhibit 64: Market opportunity by Product ($ million)
  • Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
  • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
  • Exhibit 103: Chart on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on Japan - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
  • Exhibit 115: Abbott Laboratories - Overview
  • Exhibit 116: Abbott Laboratories - Business segments
  • Exhibit 117: Abbott Laboratories - Key news
  • Exhibit 118: Abbott Laboratories - Key offerings
  • Exhibit 119: Abbott Laboratories - Segment focus
  • 12.4 Ascensia Diabetes Care Holdings AG
  • Exhibit 120: Ascensia Diabetes Care Holdings AG - Overview
  • Exhibit 121: Ascensia Diabetes Care Holdings AG - Product / Service
  • Exhibit 122: Ascensia Diabetes Care Holdings AG - Key offerings
  • 12.5 Dexcom Inc.
  • Exhibit 123: Dexcom Inc. - Overview
  • Exhibit 124: Dexcom Inc. - Product / Service
  • Exhibit 125: Dexcom Inc. - Key news
  • Exhibit 126: Dexcom Inc. - Key offerings
  • 12.6 DiaMonTech AG
  • Exhibit 127: DiaMonTech AG - Overview
  • Exhibit 128: DiaMonTech AG - Product / Service
  • Exhibit 129: DiaMonTech AG - Key offerings
  • 12.7 F. Hoffmann La Roche Ltd.
  • Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.8 GlySens Inc.
  • Exhibit 135: GlySens Inc. - Overview
  • Exhibit 136: GlySens Inc. - Product / Service
  • Exhibit 137: GlySens Inc. - Key offerings
  • 12.9 Health Arx Technologies Pvt. Ltd.
  • Exhibit 138: Health Arx Technologies Pvt. Ltd. - Overview
  • Exhibit 139: Health Arx Technologies Pvt. Ltd. - Product / Service
  • Exhibit 140: Health Arx Technologies Pvt. Ltd. - Key offerings
  • 12.10 Insulet Corp.
  • Exhibit 141: Insulet Corp. - Overview
  • Exhibit 142: Insulet Corp. - Product / Service
  • Exhibit 143: Insulet Corp. - Key news
  • Exhibit 144: Insulet Corp. - Key offerings
  • 12.11 Medtronic Plc
  • Exhibit 145: Medtronic Plc - Overview
  • Exhibit 146: Medtronic Plc - Business segments
  • Exhibit 147: Medtronic Plc - Key news
  • Exhibit 148: Medtronic Plc - Key offerings
  • Exhibit 149: Medtronic Plc - Segment focus
  • 12.12 Medtrum Technologies Inc.
  • Exhibit 150: Medtrum Technologies Inc. - Overview
  • Exhibit 151: Medtrum Technologies Inc. - Product / Service
  • Exhibit 152: Medtrum Technologies Inc. - Key offerings
  • 12.13 Novo Nordisk AS
  • Exhibit 153: Novo Nordisk AS - Overview
  • Exhibit 154: Novo Nordisk AS - Business segments
  • Exhibit 155: Novo Nordisk AS - Key offerings
  • Exhibit 156: Novo Nordisk AS - Segment focus
  • 12.14 Sanofi SA
  • Exhibit 157: Sanofi SA - Overview
  • Exhibit 158: Sanofi SA - Business segments
  • Exhibit 159: Sanofi SA - Key news
  • Exhibit 160: Sanofi SA - Key offerings
  • Exhibit 161: Sanofi SA - Segment focus
  • 12.15 Senseonics Holdings Inc.
  • Exhibit 162: Senseonics Holdings Inc. - Overview
  • Exhibit 163: Senseonics Holdings Inc. - Product / Service
  • Exhibit 164: Senseonics Holdings Inc. - Key offerings
  • 12.16 SFC Fluidics Inc.
  • Exhibit 165: SFC Fluidics Inc. - Overview
  • Exhibit 166: SFC Fluidics Inc. - Product / Service
  • Exhibit 167: SFC Fluidics Inc. - Key offerings
  • 12.17 Ypsomed AG
  • Exhibit 168: Ypsomed AG - Overview
  • Exhibit 169: Ypsomed AG - Business segments
  • Exhibit 170: Ypsomed AG - Key offerings
  • Exhibit 171: Ypsomed AG - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 172: Inclusions checklist
  • Exhibit 173: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 174: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 175: Research methodology
  • Exhibit 176: Validation techniques employed for market sizing
  • Exhibit 177: Information sources
  • 13.5 List of abbreviations
  • Exhibit 178: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제